Recently, hematopoietic stem cells (identified as CD133+CD34+CD45+ cells) were also found in the peripheral blood of patients with lung cancer, and their number negatively correlated with time to progression (Vroling et al. 2010). The gene discussed is PTPRC; the disease is lung carcinoma.